HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Data Supplement Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Knoechel, B. Articles by Abbas, A. K. Search for Related Content PubMed PubMed Citation Articles by Knoechel, B. Articles by Abbas, A. K.

Functional and Molecular Comparison of Anergic and Regulatory T Lymphocytes¹

Birgit Knoechel^2,*, Jens Lohr^2,*, Shirley Zhu, Lisa Wong, Donglei Hu, Lara Ausubel^3,* and Abul K. Abbas^4,*

^* Department of Pathology and Diabetes Center, University of California San Francisco School of Medicine, San Francisco, California 94143

Tolerance in vivo is maintained by multiple mechanisms that function to prevent autoimmunity. An encounter of CD4⁺ T cells with a circulating self-Ag leads to partial thymic deletion, the development of CD25⁺ regulatory T cells (Tregs), and functional anergy in the surviving CD25^– population. We have compared anergic and regulatory T cells of the same Ag specificity generated in vivo by the systemic self-Ag. Anergic cells are unresponsive to the self-Ag that induces tolerance, but upon transfer into a new host and immunization, anergic cells can induce a pathologic autoimmune reaction against tissue expressing the same Ag. Tregs, in contrast, are incapable of mediating harmful reactions. To define the basis of this functional difference, we have compared gene expression profiles of anergic and regulatory T cells. These analyses show that Tregs express a distinct molecular signature, but anergic cells largely lack such a profile. Anergic cells express transcripts that are associated with effector differentiation, e.g., the effector cytokines IL-4 and IFN-. Anergic cells do not produce these cytokines in response to self-Ag, because the cells exhibit a proximal signaling block in response to TCR engagement. Thus, anergy reflects an aborted activation pathway that can readily be reversed, resulting in pathologic effector cell responses, whereas Treg development follows a distinct developmental pathway that extinguishes effector functions.

This article has been cited by other articles:

				L. Barron, B. Knoechel, J. Lohr, and A. K. Abbas Cutting Edge: Contributions of Apoptosis and Anergy to Systemic T Cell Tolerance J. Immunol., March 1, 2008; 180(5): 2762 - 2766. [Abstract] [Full Text] [PDF]

				W. Hansen, A. M. Westendorf, S. Reinwald, D. Bruder, S. Deppenmeier, L. Groebe, M. Probst-Kepper, A. D. Gruber, R. Geffers, and J. Buer Chronic Antigen Stimulation In Vivo Induces a Distinct Population of Antigen-Specific Foxp3 CD25 Regulatory T Cells J. Immunol., December 15, 2007; 179(12): 8059 - 8068. [Abstract] [Full Text] [PDF]

				S. A. Joosten, K. E. van Meijgaarden, N. D. L. Savage, T. de Boer, F. Triebel, A. van der Wal, E. de Heer, M. R. Klein, A. Geluk, and T. H. M. Ottenhoff Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4 PNAS, May 8, 2007; 104(19): 8029 - 8034. [Abstract] [Full Text] [PDF]

				J. Lohr, B. Knoechel, J. J. Wang, A. V. Villarino, and A. K. Abbas Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease J. Exp. Med., December 25, 2006; 203(13): 2785 - 2791. [Abstract] [Full Text] [PDF]